Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

VViatris Inc

EconomyAI buildoutMarket MapFundsWatchlist
Log in
V

Viatris Inc

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • History
  • News
  • Insider Transactions

News

News

  • Viatris Announces Approval of WAKIX® (Pitolisant) in Japan, a First-in-Class Treatment for Narcolepsy and Excessive Daytime Sleepiness Associated With Obstructive Sleep Apnea Syndrome
    Sep 16, 2026Press Releases | Viatris
  • Viatris Reports Second-Quarter 2026 Financial Results
    Aug 6, 2026Press Releases | Viatris
  • Viatris Announces Quarterly Dividend
    Aug 4, 2026Press Releases | Viatris
  • Viatris Receives U.S. FDA Approval for Gwyn Lo™, a Once-Weekly Contraceptive Patch
    Jul 29, 2026Press Releases | Viatris
  • Viatris to Report Second-Quarter 2026 Financial Results on August 6, 2026
    Jul 1, 2026Press Releases | Viatris
  • Viatris Announces Positive Top-Line Results from Phase 3 Study of VR-205 in Japanese Adults with Primary Immunoglobulin A Nephropathy
    Jun 29, 2026Press Releases | Viatris
  • U.S. FDA Accepts Viatris New Drug Application for Fast-Acting Meloxicam for the Treatment of Moderate-to-Severe Acute Pain
    May 18, 2026Press Releases | Viatris
  • Viatris to Present at the Bank of America Securities 2026 Healthcare Conference
    May 7, 2026Press Releases | Viatris
  • Viatris Reports First-Quarter 2026 Financial Results
    May 7, 2026Press Releases | Viatris
  • Viatris Announces Quarterly Dividend
    May 5, 2026Press Releases | Viatris
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • History
  • News
  • Insider Transactions